• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Identification of atrial fibrillation phenotypes at low risk of stroke in patients with CHA2DS2-VASc ≥2: Insight from the China-AF study.

作者信息

Jiang Chao, Li Mingxiao, Hu Yiying, Du Xin, Li Xiang, He Liu, Lai Yiwei, Chen Tiange, Li Yingxue, Guo Xueyuan, Jiang Chenxi, Tang Ribo, Sang Caihua, Long Deyong, Xie Guotong, Dong Jianzeng, Ma Changsheng

机构信息

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China.

Ping An Health Technology, Beijing, China.

出版信息

Pacing Clin Electrophysiol. 2023 Oct;46(10):1203-1211. doi: 10.1111/pace.14829. Epub 2023 Sep 22.

DOI:10.1111/pace.14829
PMID:37736697
Abstract

OBJECTIVE

Patients with atrial fibrillation (AF) are highly heterogeneous, and current risk stratification scores are only modestly good at predicting an individual's stroke risk. We aim to identify distinct AF clinical phenotypes with cluster analysis to optimize stroke prevention practices.

METHODS

From the prospective Chinese Atrial Fibrillation Registry cohort study, we included 4337 AF patients with CHA DS -VASc≥2 for males and 3 for females who were not treated with oral anticoagulation. We randomly split the patients into derivation and validation sets by a ratio of 7:3. In the derivation set, we used outcome-driven patient clustering with metric learning to group patients into clusters with different risk levels of ischemic stroke and systemic embolism, and identify clusters of patients with low risks. Then we tested the results in the validation set, using the clustering rules generated from the derivation set. Finally, the survival decision tree was applied as a sensitivity analysis to confirm the results.

RESULTS

Up to the follow-up of 1 year, 140 thromboembolic events (ischemic stroke or systemic embolism) occurred. After supervised metric learning from six variables involved in CHA DS -VASc scheme, we identified a cluster of patients (255/3035, 8.4%) at an annual thromboembolism risk of 0.8% in the derivation set. None of the patients in the low-risk cluster had prior thromboembolism, heart failure, diabetes, or age older than 70 years. After applying the regularities from metric learning on the validation set, we also identified a cluster of patients (137/1302, 10.5%) with an incident thromboembolism rate of 0.7%. Sensitivity analysis based on the survival decision tree approach selected a subgroup of patients with the same phenotypes as the metric-learning algorithm.

CONCLUSIONS

Cluster analysis identified a distinct clinical phenotype at low risk of stroke among high-risk [CHA DS -VASc≥2 (3 for females)] patients with AF. The use of the novel analytic approach has the potential to prevent a subset of AF patients from unnecessary anticoagulation and avoid the associated risk of major bleeding.

摘要

相似文献

1
Identification of atrial fibrillation phenotypes at low risk of stroke in patients with CHA2DS2-VASc ≥2: Insight from the China-AF study.
Pacing Clin Electrophysiol. 2023 Oct;46(10):1203-1211. doi: 10.1111/pace.14829. Epub 2023 Sep 22.
2
Association of CHA DS -VASc Score with Stroke, Thromboembolism, and Death in Hip Fracture Patients.CHA2DS2-VASc 评分与髋部骨折患者的中风、血栓栓塞和死亡的关系。
J Am Geriatr Soc. 2020 Aug;68(8):1698-1705. doi: 10.1111/jgs.16452. Epub 2020 Apr 15.
3
Augmented intelligence decision tool for stroke prediction combines factors from CHA DS -VASc and the intermountain risk score for patients with atrial fibrillation.增强型人工智能决策工具用于预测中风,结合了 CHA2DS2-VASc 和房颤患者的山间风险评分的因素。
J Cardiovasc Electrophysiol. 2019 Sep;30(9):1452-1461. doi: 10.1111/jce.13999. Epub 2019 Jun 25.
4
Predicting stroke in patients without atrial fibrillation.预测无房颤患者的中风情况。
Eur J Clin Invest. 2019 Jun;49(6):e13103. doi: 10.1111/eci.13103. Epub 2019 Apr 3.
5
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).心房颤动抗凝治疗患者血栓栓塞和出血事件的风险因素:前瞻性、多中心观察性预防血栓栓塞事件-心房颤动欧洲登记研究(PREFER in AF)。
BMJ Open. 2019 Mar 30;9(3):e022478. doi: 10.1136/bmjopen-2018-022478.
6
Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.评估 CHA2DS2-VASc 评分在伴有和不伴有心房颤动的心力衰竭患者中预测缺血性卒、血栓栓塞和死亡的价值。
JAMA. 2015 Sep 8;314(10):1030-8. doi: 10.1001/jama.2015.10725.
7
Refinement of ischemic stroke risk in patients with atrial fibrillation and CHA2 DS2 -VASc score of 1.心房颤动且CHA2 DS2 -VASc评分为1分患者缺血性中风风险的细化
Pacing Clin Electrophysiol. 2014 Nov;37(11):1442-7. doi: 10.1111/pace.12445. Epub 2014 Jul 16.
8
Do physicians correctly calculate thromboembolic risk scores? A comparison of concordance between manual and computer-based calculation of CHADS2 and CHA2 DS2 -VASc scores.医生是否正确计算血栓栓塞风险评分?CHADS2和CHA2 DS2 -VASc评分手动计算与基于计算机计算的一致性比较。
Intern Med J. 2016 May;46(5):583-9. doi: 10.1111/imj.13048.
9
[The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].[不同临床特征的低风险心房颤动患者的血栓栓塞风险]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Sep 24;48(9):735-739. doi: 10.3760/cma.j.cn112148-20200306-00164.
10
The role of CHADS2 and CHA2 DS2 -VASc scores in the prediction of stroke in individuals without atrial fibrillation: a population-based study.CHADS2 和 CHA2DS2-VASc 评分在预测无房颤个体中风中的作用:一项基于人群的研究。
J Thromb Haemost. 2016 Jun;14(6):1155-62. doi: 10.1111/jth.13324. Epub 2016 May 31.